Pharma Journalist - Page 82 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

CHMP Recommends EU Approval of Imfinzi-based Regimen for Resectable NSCLC

FDA Approves Genentech’s TNKase for Acute Ischemic Stroke in Adults

WuXi Biologics Unveils EffiX Platform to Enhance Protein and DNA Production

BridgeBio Oncology and Helix Acquisition Announce Business Merger to Advance RAS, PI3Kα Medicines

Magnet Biomedicine and Lilly Partner to Develop Novel Molecular Glue Medicines

FDA Grants Priority Review to Sobi’s sBLA for Gamifant (emapalumab-lzsg)

Medigene and EpimAb Partner on Co-Development of TCR-Guided T Cell Engagers

FDA Accepts BLA for Odronextamab in Treating Relapsed/Refractory Follicular Lymphoma

Lilly to Exceed $50 Billion in U.S. Manufacturing Investment, Doubling Since 2020

Sarclisa Approved in Japan for Newly Diagnosed Multiple Myeloma Patients